| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/20/2003 | WO2003014306A2 Antisense modulation of cholesteryl ester transfer protein expression |
| 02/20/2003 | WO2003014298A2 Full-length prostate selective polynucleotides and polypeptides |
| 02/20/2003 | WO2003014143A2 Haplotype map of the human genome and uses therefor |
| 02/20/2003 | WO2003014138A2 Method for immobilizing compounds by means of nitron formation and arrangement for immobilizing compounds |
| 02/20/2003 | WO2002096262A3 Non-alloying core shell nanoparticles |
| 02/20/2003 | WO2002090516A3 Design of artificial genes for use as controls in gene expression analysis systems |
| 02/20/2003 | WO2002083849A3 Vascular endothelial growth factor 2 |
| 02/20/2003 | WO2002061057A3 Regulation of human wee1-like serine/threonine protein kinase |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2001053538A3 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease |
| 02/20/2003 | US20030036649 2' modified oligonucleotides |
| 02/20/2003 | US20030036645 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 02/20/2003 | US20030036642 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/20/2003 | US20030036635 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036634 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036527 Promoting mucociliary or cough clearance of retained mucus secretions from the lungs, sinuses, upper airways, ears, eyes, genitourinary tract, spermatozoa, ovaries, fallopian tubes, neutrophils, and macrophages |
| 02/20/2003 | US20030036516 Method for using oligonucleotides having modified cpg dinucleotides |
| 02/20/2003 | US20030036507 Urocortin-III and uses thereof |
| 02/20/2003 | US20030036505 Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon |
| 02/20/2003 | US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036178 Long wavelength engineered fluorescent proteins |
| 02/20/2003 | US20030036175 Depletion or removal of endotoxins from solution; obtain solution, incubate with chromatographic column, elute, recover endotoxin free solution |
| 02/20/2003 | US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 02/20/2003 | US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036168 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/20/2003 | US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders |
| 02/20/2003 | US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036116 Can be used in combination with other mutagenesis methods |
| 02/20/2003 | US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders |
| 02/20/2003 | US20030036066 Linker phosphoramidites for oligonucleotide synthesis |
| 02/20/2003 | US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders |
| 02/20/2003 | US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036058 Amplification of hybridization in sample; obtain sample, incubate with primer, expose to modified monitor hybridization, compare to control |
| 02/20/2003 | US20030036053 Process for typing HCV isolates |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030035816 Soluble ctla4 mutant molecules and uses thereof |
| 02/20/2003 | US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | CA2460215A1 Haplotype map of the human genome and uses therefor |
| 02/20/2003 | CA2456857A1 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/19/2003 | EP1284421A1 Method of constructing polynucleotide microarray, apparatus for the construction and polynucleotide microarray |
| 02/19/2003 | EP1283908A1 Methods of obtaining active antisense compounds |
| 02/19/2003 | EP1087777B1 Therapeutic dinucleotide and derivatives |
| 02/19/2003 | EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 02/19/2003 | CN1398301A Process for labeling nucleic acid |
| 02/18/2003 | US6521775 Genetically engineered oligonucleotides for use as diagnostic and therapeutic tools in gene therapy |
| 02/18/2003 | US6521744 Binding or complexing oligomers through hydrogen bondin, van der Waals interaction, pi stacking or condensation |
| 02/18/2003 | US6521739 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey |
| 02/18/2003 | US6521601 Selecting a DNA fragment having sequence recognized by a viral specific transcription factor and complementary segment |
| 02/18/2003 | US6521440 Proteases from gram-positive organisms |
| 02/18/2003 | US6521434 Nucleotide sequences coding enzymatic polypeptide; for use as a bactericide |
| 02/18/2003 | US6521226 Administering Paraoxonase-1 (PON-1), an expressed protein that has hydrolase activity for organophosphates, and antioxidation activity for low-density lipoprotein (LDL) |
| 02/13/2003 | WO2003012143A1 Genes and snps associated with eating disorders |
| 02/13/2003 | WO2003012124A2 Methods for immobilizing molecules to a solid phase and uses thereof |
| 02/13/2003 | WO2003012120A2 Lp354 mammalian secreted protein |
| 02/13/2003 | WO2003012118A1 Complexity management of genomic dna |
| 02/13/2003 | WO2003012070A2 Gene associated with bone disorders |
| 02/13/2003 | WO2003012051A2 Inhibitor of dna methylation |
| 02/13/2003 | WO2003012034A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/13/2003 | WO2003011907A2 Receptor, the use thereof, and mouse antibodies |
| 02/13/2003 | WO2003011887A2 Antisense modulation of apolipoprotein b expression |
| 02/13/2003 | WO2003011878A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | WO2002079228A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/13/2003 | WO2002060454B1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/13/2003 | WO2002040701A3 Energy transfer labels with mechanically linked fluorophores |
| 02/13/2003 | WO2002006534A3 Method of diagnosing pulmonary hypertension |
| 02/13/2003 | WO2001087286A3 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 02/13/2003 | US20030032795 Synthesis of oligonucleotides on solid support |
| 02/13/2003 | US20030032794 Method for preparation of LNA phosphoramidites |
| 02/13/2003 | US20030032785 Detection of ligand and ligand sequences in sample; obtain nucleotide sequence samples, partitioning sample, incubate with primers, propagate and amplify sequences |
| 02/13/2003 | US20030032775 Effector proteins of rapamycin |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032147 Isolation of preferential nucleotide sequences; obtain sample containing nucleotide sequences, incubate with alkaline, expose to matrix consisting of chaotropic agents, elute and recover preferential nucleotide sequences |
| 02/13/2003 | US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032098 Bone morphogenic protein |
| 02/13/2003 | US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032042 Internal calibration standards for electrophoretic analyses |
| 02/13/2003 | US20030032030 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging |
| 02/13/2003 | US20030032025 Brassica polymorphisms |
| 02/13/2003 | US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 02/13/2003 | CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2456199A1 Gene associated with bone disorders |
| 02/13/2003 | CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2455228A1 Antisense modulation of apolipoprotein b expression |